Table 2. Association of IgG sensitization to dust EVs with asthma, COPD, and lung cancer by multivariable analysis.
Asthma | COPD | Lung cancer | |||||||
---|---|---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P value† | Odds ratio | 95% CI | P value† | Odds ratio | 95% CI | P value† | |
Aging | 1.03 | 1.01-1.05 | 0.002 | 1.2 | 1.1-1.2 | <0.001 | 1.2 | 1.1-1.2 | <0.001 |
Female gender | 0.7 | 0.3-1.5 | 0.352 | 1.0 | 0.3-2.8 | 0.93 | 0.7 | 0.3-1.8 | 0.45 |
Cigarette smoking | 0.3 | 0.1-0.6 | 0.001 | 3.7 | 1.4-10.1 | 0.01 | 2.7 | 1.1-7.0 | 0.03 |
Anti-EV IgG* | 3.3 | 1.1-10.0 | 0.039 | 8.0 | 2.0-3.25 | 0.003 | 38.7 | 10.4-144.3 | <0.001 |
*The positive rate of IgG sensitization to dust EVs, based on a high anti-dust EV IgG level in serum; †Logistic regression analysis vs the control group.